| 10231967 |
Compounds and their use as BACE inhibitors |
Gabor Csjernyik, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg +6 more |
2019-03-19 |
$98,045,000 |
| 9918985 |
Compounds and their use as BACE inhibitors |
Gabor Csjernyik, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg +6 more |
2018-03-20 |
$95,702,000 |
| 9248129 |
Compounds and their use as BACE inhibitors |
Gabor Csjernyik, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg +6 more |
2016-02-02 |
$14,713,000 |
| 9000184 |
Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitors |
Lars Sandberg, Peter Soderman, Karin Kolmodin, Liselotte Ohberg |
2015-04-07 |
$11,077,000 |
| 9000185 |
Cycloalkyl ether compounds and their use as BACE inhibitors |
Peter Soderman, Britt-Marie Swahn, Laszlo Rakos, Liselotte Ohberg |
2015-04-07 |
$11,077,000 |
| 9000182 |
2H-imidazol-4-amine compounds and their use as BACE inhibitors |
Gabor Csjernyik, Britt-Marie Swahn, Lars Sandberg, Karin Kolmodin, Peter Soderman +1 more |
2015-04-07 |
$11,077,000 |
| 9000183 |
Cyclohexane-1,2′-indene-1′,2″-imidazol compounds and their use as BACE inhibitors |
Peter Soderman, Laszlo Rakos, Liselotte Ohberg, Karin Kolmodin, Lars Sandberg |
2015-04-07 |
$11,077,000 |
| 8865911 |
Compounds and their use as BACE inhibitors |
Gabor Csjernyik, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg +6 more |
2014-10-21 |
$23,633,000 |
| 8415483 |
Compounds and their use as BACE inhibitors |
Gabor Csjernyik, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg +6 more |
2013-04-09 |
$7,902,000 |
| 8158785 |
5,7-disubstituted[1.3]thiazolo [4,5-D] pyrimidin-2(3H)-amine derivatives and their use in therapy |
Rolf Johansson, Annika Kers, Gunnar Nordvall, Tobias Rein, Can Slivo |
2012-04-17 |
$6,204,000 |
| 8030500 |
Substituted isoindoles for the treatment and/or prevention of Aβ- related pathologies |
Jörg Holenz, Karin Kolmodin, Johan Lindström, Laszlo Rakos, Didier Rotticci +3 more |
2011-10-04 |
$8,688,000 |
| 7960395 |
5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors |
Rolf Johansson, Annika Kers, Gunnar Nordvall, Tobias Rein, Can Slivo |
2011-06-14 |
$4,075,000 |
